Treatment of Uric Acid With the Xanthine Oxidase Inhibitor Febuxostat: Effects on Blood Pressure, Metabolic Markers, and Aortic Stiffness in Prehypertensive
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Febuxostat (Primary)
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 25 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 19 Nov 2011 New trial record